To ask the Secretary of State for Health and Social Care, in the context of potential depletion in covid-19 vaccine efficacy, what steps his Department is taking to help ensure ongoing protections against covid-19.
We have secured early access to 453.5 million vaccines doses through supply agreements with six vaccine developers. We have also signed contracts to procure a further 4.98 million courses of antivirals for the National Health Service. The highest risk patients in the United Kingdom are already able to access molnupiravir, an antiviral treatment, as well as monoclonal antibody treatments from COVID Medicines Delivery Units. In addition, oral antiviral treatments are available through the PANORAMIC national study, run by the University of Oxford. This study is open to clinically eligible individuals living in the UK. The Government will set out further plans on managing the COVID-19 virus in due course.